Results 31 to 40 of about 10,795 (199)

Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient

Lung India, 2014
Pulmonary alveolar proteinosis (PAP) is an orphan disease characterized by the accumulation of excess of surfactant within alveoli and bronchioles. The primary form of PAP (P-PAP; also referred to as idiopathic or autoimmune) is the most common form.
Ashfaq Hasan, Raja Ram, TLN Swamy
doaj   +1 more source

s-cyclophilin is retained intracellularly via a unique COOH-terminal sequence and colocalizes with the calcium storage protein calreticulin [PDF]

, 1992
Cyclophilins (cyclosporin A-binding proteins) are conserved, ubiquitous, and abundant proteins that accelerate the isomerization of XaaPro peptide bonds and the refolding of proteins in vitro.
Arber, S., P Caroni, Krause, Karl-Heinz, K H Krause, S Arber, Caroni, P., Krause, K. H.   +6 more
core   +1 more source

Open-label non-blinded cohort study on anti-histaminic resistant chronic idiopathic urticaria in Western India

Indian Journal of Dermatology, 2022
Introduction: Chronic idiopathic urticaria (CIU) is a chronic relapsing disease with hives for a period of six weeks or more. It has a significant impact on the physical and mental well-being of patients. Aims and Objectives: Open-label non-blinded study
Subramanian Natarajan, Poonam Subramanian   +1 more
doaj   +1 more source

Efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis

Pifu-xingbing zhenliaoxue zazhi, 2023
Objective To assess the clinical efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis. Methods Ninety-one patients with nail psoriasis from our hospital were randomly divided into cyclosporin group (30 cases),
Zhanhan TANG, Sushan LI, Sha LV, Zhao HUANG, Zhe LIU, Fuqiu LI   +5 more
doaj   +1 more source

Effect of Cyclosporine on Lesion Growth and Infarct Size within the White and Gray Matter

Frontiers in Neurology, 2017
BackgroundIn a recent trial, cyclosporine A (CsA) failed to reduce infarct size in acute stroke patients treated with intravenous thrombolysis. White matter (WM) and gray matter (GM) may have distinct vulnerability to ischemia and response to therapy ...
Tae-Hee Cho, Tae-Hee Cho, Tae-Hee Cho, Tae-Hee Cho, Tae-Hee Cho, Elodie Ong, Elodie Ong, Elodie Ong, Elodie Ong, Elodie Ong, Nathan Mewton, Nathan Mewton, Nathan Mewton, Julien Bouvier, Julien Bouvier, Julien Bouvier, Julien Bouvier, Julien Bouvier, Fabien Chauveau, Fabien Chauveau, Fabien Chauveau, Thomas Ritzenthaler, Thomas Ritzenthaler, Thomas Ritzenthaler, Thomas Ritzenthaler, Thomas Ritzenthaler, Laura Mechtouff, Laura Mechtouff, Laura Mechtouff, Laura Mechtouff, Laura Mechtouff, Laurent Derex, Laurent Derex, Laurent Derex, Laurent Derex, Laurent Derex, Marielle Buisson, Marielle Buisson, Marielle Buisson, Yves Berthezène, Yves Berthezène, Yves Berthezène, Yves Berthezène, Yves Berthezène, Michel Ovize, Michel Ovize, Michel Ovize, Norbert Nighoghossian, Norbert Nighoghossian, Norbert Nighoghossian, Norbert Nighoghossian, Norbert Nighoghossian   +51 more
doaj   +1 more source

Evidence that inhibition of phorbol ester-induced superoxide anion formation by cyclosporin A in phagocytes is not mediated by direct inhibition of protein kinase C

, 1994
Cyclosporin A (CsA) has been reported to inhibit phorbol myristate acetate (PMA)-induced superoxide anion (O2-) formation in human neutrophils and murine macrophages.
Grünbaum, L., Hummel, R., Schächtele, C., Wenzel-Seifert, K., Seifert, Roland   +4 more
core   +1 more source

Treatment of atopic dermatitis with cyclosporin A: a case report

, 2017
Introduction . Despite the progress that has been made in the therapy of atopic dermatitis in recent years, cyclosporin A remains the first-line treatment of severe forms of the disease. Objective.
Adam Reich, Karolina Kaaz
core   +1 more source

Preferential Solvation of Cyclosporin in Aqueous Mixtures of Some Polymeric Cosolvents [PDF]

ImmunoAnalysis
Background: Cyclosporin is a cyclic peptide-drug used as immunosuppressant for the prophylaxisof transplant rejection whose physicochemical properties in mixed aqueous solvent systems isstill not well understood.
María Ángeles Peña, Olga E. García-Serna, Darío A. Tinjacá, Daniel R. Delgado, Fleming Martínez   +4 more
doaj   +1 more source

Analysis of the Treatment Efficacy in Late Diagnosis of Alport Syndrome in a Child: Clinical Case

Вопросы современной педиатрии, 2023
Background. Alport syndrome is a systemic, hereditary, progressive disease characterized by ultrastructural changes in the glomerular basement membrane caused by pathogenic variants of type IV collagen genes.
Svetlana Ya. Volgina, Nailya A. Solovyeva, Galina A. Kulakova, Elena A. Kurmayeva, Liliya I. Mukhametdinova, Elina L. Rashitova   +5 more
doaj   +1 more source

Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa [PDF]

, 1988
Cyclophilin (cyclosporin A-binding protein) has a dual localization in the mitochondria and in the cytosol of Neurospora crassa. The two forms are encoded by a single gene which is transcribed into mRNAs having different lengths and 5' termini ...
Tropschug, Maximilian, Pfanner, Nikolaus, Hartl, Franz-Ulrich, Wachter, Elmar, Neupert, Walter, Köhler, Helmut, Nicholson, Donald W.   +6 more
core